Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Mindset Pharma Inc. MSSTF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score
29/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Mindset Pharma Inc. (MSSTF) is a Biotechnology company in the Healthcare sector, currently trading at $0.54. It has a SharesGrow Score of 28/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Financials: revenue is $4M, +0%/yr average growth. Net income is $17M (loss), growing at -11761.1%/yr. Net profit margin is -425.2% (negative). Gross margin is 100% (+0 pp trend).

Balance sheet: total debt is $171,794 against $1M equity (Debt-to-Equity (D/E) ratio 0.12, conservative). Current ratio is 1.18 (adequate). Debt-to-assets is 1.8%. Total assets: $10M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 75/100 (Pass), Moat 46/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

MSSTF SharesGrow Score Overview

37/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 75/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 46/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MSSTF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
MSSTF: +0%/yr revenue is, -11761.1%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✓
HEALTH Pass
75/100
Balance sheet MSSTF: Debt-to-Equity (D/E) ratio 0.12 (conservative), Current ratio is 1.18 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
46/100
MSSTF: Gross margin is 100% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 46/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
MSSTF: Net profit margin is -425.2%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.1626-0.559
Volume900
Avg Volume (30D)57.61K
Market Cap$54.51M
Beta (1Y)-0.10
Share Statistics
EPS (TTM)-0.18
Shares Outstanding$90.06M
IPO Date2021-02-08
CEOJames Andre-Charles Lanthier
Financial Highlights & Ratios
Revenue (TTM)$3.91M
Gross Profit$3.91M
EBITDA$-16.53M
Net Income$-16.61M
Operating Income$-16.58M
Total Cash$8.71M
Total Debt$171.79K
Net Debt$-8.54M
Total Assets$9.77M
Price / Earnings (P/E)-3
Price / Sales (P/S)13.95
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD

Price Chart

Track all markets on TradingView
MSSTF
Mindset Pharma Inc. ↗  ·  Other OTC
Healthcare • Biotechnology
0.16 52WK RANGE 0.56

People Also View

GHRS
GHRS
GH Research PLC
$17.00
+1.37%
 FBIOP
FBIOP
Fortress Biotech, Inc.
$13.21
-1.20%
 BSTG
BSTG
Biostage, Inc.
$4.03
+0.75%
 TRYPF
TRYPF
Tryp Therapeutics Inc.
$0.06
+32.24%
 AWKNF
AWKNF
Awakn Life Sciences Corp.
$0.07
+0.00%
 AXIM
AXIM
AXIM Biotechnologies, Inc.
$0.01
+0.32%
 HESG
HESG
Health Sciences Group, Inc.
$0.00
+0.00%
 AGNPF
AGNPF
Algernon Pharmaceuticals Inc.
$0.04
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message